Literature DB >> 23305715

Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012.

J van Beek1, K Ambert-Balay, N Botteldoorn, J S Eden, J Fonager, J Hewitt, N Iritani, A Kroneman, H Vennema, J Vinjé, P A White, M Koopmans.   

Abstract

Globally, surveillance systems showed an increasein norovirus activity in late 2012. Molecular datashared through the NoroNet network suggest thatthis increase is related to the emergence of a newnorovirus genotype II.4 variant, termed Sydney 2012.Healthcare institutions are advised to be prepared fora severe norovirus season.

Mesh：

Substances：

Year:  2013        PMID： 23305715

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  122 in total

1.  Environmental Surveillance for Noroviruses in Selected South African Wastewaters 2015-2016: Emergence of the Novel GII.17.

Authors:  V V Mabasa; K D Meno; M B Taylor; Janet Mans
Journal:  Food Environ Virol       Date:  2017-08-04       Impact factor: 2.778

2.  Comparative genome analysis of a norovirus GII.4 strain GZ2013-L10 isolated from South China.

Authors:  Liang Xue; Weicheng Cai; Qingping Wu; Xiaoxia Kou; Jumei Zhang; Weipeng Guo
Journal:  Virus Genes       Date:  2016-01-04       Impact factor: 2.332

3.  Molecular epidemiology of oyster-related human noroviruses and their global genetic diversity and temporal-geographical distribution from 1983 to 2014.

Authors:  Yongxin Yu; Hui Cai; Linghao Hu; Rongwei Lei; Yingjie Pan; Shuling Yan; Yongjie Wang
Journal:  Appl Environ Microbiol       Date:  2015-08-28       Impact factor: 4.792

4.  Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.

Authors:  Kari Debbink; Lisa C Lindesmith; Eric F Donaldson; Veronica Costantini; Martina Beltramello; Davide Corti; Jesica Swanstrom; Antonio Lanzavecchia; Jan Vinjé; Ralph S Baric
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

5.  Evidence for recombination between pandemic GII.4 norovirus strains New Orleans 2009 and Sydney 2012.

Authors:  V Martella; M C Medici; S De Grazia; F Tummolo; A Calderaro; F Bonura; L Saporito; V Terio; C Catella; G Lanave; C Buonavoglia; G M Giammanco
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

6.  New strains of norovirus and the mystery of viral gastroenteritis epidemics.

Authors:  Bonita E Lee; Xiao-Li Pang
Journal:  CMAJ       Date:  2013-09-03       Impact factor: 8.262

7.  Avidity of α-fucose on human milk oligosaccharides and blood group-unrelated oligo/polyfucoses is essential for potent norovirus-binding targets.

Authors:  Franz-Georg Hanisch; Grant S Hansman; Vasily Morozov; Clemens Kunz; Horst Schroten
Journal:  J Biol Chem       Date:  2018-06-01       Impact factor: 5.157

8.  Recombination within the pandemic norovirus GII.4 lineage.

Authors:  John-Sebastian Eden; Mark M Tanaka; Maciej F Boni; William D Rawlinson; Peter A White
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

9.  Proposal for a unified norovirus nomenclature and genotyping.

Authors:  Annelies Kroneman; Everardo Vega; Harry Vennema; Jan Vinjé; Peter A White; Grant Hansman; Kim Green; Vito Martella; Kazuhiko Katayama; Marion Koopmans
Journal:  Arch Virol       Date:  2013-04-25       Impact factor: 2.574

10.  Emergence of a novel GII.17 norovirus – End of the GII.4 era?

Authors:  M de Graaf; J van Beek; H Vennema; A T Podkolzin; J Hewitt; F Bucardo; K Templeton; J Mans; J Nordgren; G Reuter; M Lynch; L D Rasmussen; N Iritani; M C Chan; V Martella; K Ambert-Balay; J Vinjé; P A White; M P Koopmans
Journal:  Euro Surveill       Date:  2015-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.